EGFR and bone metastasis: Overall, statistically significant differences were observed in the distribution of age, AJCC T stage, bone metastasis, pathological type, EGFR mutation status, surgery, chemotherapy, radiotherapy, EGFR-TKI treatment, and ICIs treatment between the male and female groups (P < 0.05).